| 摘要 |
PCT No. PCT/PL96/00010 Sec. 371 Date Nov. 14, 1997 Sec. 102(e) Date Nov. 14, 1997 PCT Filed May 13, 1996 PCT Pub. No. WO96/36354 PCT Pub. Date Nov. 21, 1996Genetic anticancer vaccine for stimulation of patient's immune system to eradicate cancer, particularly malignant melanoma. The objective of the invention is genetic modification of allogeneic cancel cells by insertion of the two genes, one encoding human interleukin 6 and the other encoding soluble interleukin 6 receptor, which will be administered to patients. |
